Recombinant Human IFN-beta 1a (Mammalian) Protein, CF
Recombinant Human IFN-beta 1a (Mammalian) Protein, CF Summary
Product Specifications
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
11410-2
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Store the unopened product at 2 - 8 °C. Do not use past expiration date. |
Reconstitution Calculator
Background: IFN-beta
Interferon-beta (IFN-beta) is a cytokine that is produced by fibroblasts and pathogen-exposed dendritic cells, macrophages, and endothelial cells. It signals through the heterodimeric IFN-alpha/beta Receptor. IFN-beta-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis (EAE), a disease model of human multiple sclerosis (MS). Furthermore, IFN-beta has been shown to suppress the Th17 cell response in both MS and EAE and has commonly been used as a treatment for MS.
Citations for Recombinant Human IFN-beta 1a (Mammalian) Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
7
Citations: Showing 1 - 7
Filter your results:
Filter by:
-
Decreased expression of miR-29 family associated with autoimmune myasthenia gravis
Authors: MA Cron, CA Payet, OM Fayet, S Maillard, F Truffault, E Fadel, J Guihaire, S Berrih-Akn, A Liston, R Le Panse
J Neuroinflammation, 2020-10-08;17(1):294.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-beta Therapy.
Authors: Rasouli J, Ciric B, Imitola J, Gonnella P, Hwang D, Mahajan K, Mari E, Safavi F, Leist T, Zhang G, Rostami A
J Immunol, 2015-04-27;194(11):5085-93.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
A 20-amino-acid deletion in the neuraminidase stalk and a five-amino-acid deletion in the NS1 protein both contribute to the pathogenicity of H5N1 avian influenza viruses in mallard ducks.
Authors: Li, Yanfang, Chen, Sujuan, Zhang, Xiaojian, Fu, Qiang, Zhang, Zhiye, Shi, Shaohua, Zhu, Yinbiao, Gu, Min, Peng, Daxin, Liu, Xiufan
PLoS ONE, 2014-04-17;9(4):e95539.
Species: Primate
Sample Types: Whole Cells
Applications: Bioassay -
Dual regulation of osteopontin production by TLR stimulation in dendritic cells.
Authors: Salvi V, Scutera S, Rossi S, Zucca M, Alessandria M, Greco D, Bosisio D, Sozzani S, Musso T
J Leukoc Biol, 2013-04-22;94(1):147-58.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses.
Authors: Wang, Bei, Xi, Xueyan, Lei, Xiaobo, Zhang, Xiaoyan, Cui, Sheng, Wang, Jianwei, Jin, Qi, Zhao, Zhendong
PLoS Pathog, 2013-03-21;9(3):e1003231.
Species: Human
Sample Types: Recombinant Protein
Applications: Bioassay -
Dobrava-Belgrade hantavirus from Germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans.
Authors: Popugaeva E, Witkowski PT, Schlegel M, Ulrich RG, Auste B, Rang A, Kruger DH, Klempa B
PLoS ONE, 2012-04-24;7(4):e35587.
Species: Human
Sample Types: Whole Cells
Applications: Control -
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines.
Authors: Witte K, Gruetz G, Volk HD, Looman AC, Asadullah K, Sterry W, Sabat R, Wolk K
Genes Immun., 2009-10-01;10(8):702-14.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
-
Why is recombinant Human Interferon-beta 1a (Catalog #'s 11415-1 and 11410-2) formulated with acetic acid?
Acetic acid was added to prevent aggregation.
Reviews for Recombinant Human IFN-beta 1a (Mammalian) Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human IFN-beta 1a (Mammalian) Protein, CF and earn rewards!
Have you used Recombinant Human IFN-beta 1a (Mammalian) Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image